No description available.

<p>Stem cells have the capacity for both self renewal, and to form all cell types in the body. Interestingly, so called neural stem cells (NSCs) are found in the adult human brain, which is of significance both out of a developmental perspective and from a clinical point of view. At the present moment, the regulation of neural stem cell (NSC) proliferation and fate determination is not completely understood.</p><p>The overall aim of this thesis was to study the mechanisms that regulate NSC proliferation and fate determination <i>in vitro</i> and <i>in vivo</i>. In particular, the roles of the female sex hormone estrogen and the testosterone analogue nandrolone, as well as the melanocortin α-melanocyte stimulating hormone (α-MSH), were analyzed in this context. Also, the breast cancer susceptibility gene one (BRCA-1), was studied in the brain with emphasis on regions containing NSCs.</p><p>Our findings show that estrogen and nandrolone have similar effects on NSCs; both decreased NSC proliferation and increased neurogenesis. Estrogen's ability to reduce proliferation was due to increased levels of p21, an inhibitor of cyclin dependent kinases. In contrast, no change in p21 was observed in the case of nandrolone, indicating differential regulation. Adult rats subjected to nandrolone injections had 30% reduced NSC proliferation in the dentate gyrus, indicating profound effects on NSCs <i>in vivo</i>.</p><p>The melanocortin α-MSH acted as a mitogen by increasing levels of cyclinD1 and retinoblastoma protein; as a result NSC proliferation was doubled.</p><p>Finally, BRCA-1 is expressed while NSCs proliferate, but is drastically down regulated upon differentiation, indicating that BRCA-1 could be used as a possible NSC marker.</p><p>In summary, in this thesis estrogen and nandrolone were identified as NSC regulators which decrease proliferation and positively influence neurogenesis. Also, we have identified the hormone α-MSH as a NSC mitogen, and BRCA-1 as a possible NSC marker.</p>

Stem cells have the capacity for both self renewal, and to form all cell types in the body. Interestingly, so called neural stem cells (NSCs) are found in the adult human brain, which is of significance both out of a developmental perspective and from a clinical point of view. At the present moment, the regulation of neural stem cell (NSC) proliferation and fate determination is not completely understood. The overall aim of this thesis was to study the mechanisms that regulate NSC proliferation and fate determination in vitro and in vivo. In particular, the roles of the female sex hormone estrogen and the testosterone analogue nandrolone, as well as the melanocortin α-melanocyte stimulating hormone (α-MSH), were analyzed in this context. Also, the breast cancer susceptibility gene one (BRCA-1), was studied in the brain with emphasis on regions containing NSCs. Our findings show that estrogen and nandrolone have similar effects on NSCs; both decreased NSC proliferation and increased neurogenesis. Estrogen's ability to reduce proliferation was due to increased levels of p21, an inhibitor of cyclin dependent kinases. In contrast, no change in p21 was observed in the case of nandrolone, indicating differential regulation. Adult rats subjected to nandrolone injections had 30% reduced NSC proliferation in the dentate gyrus, indicating profound effects on NSCs in vivo. The melanocortin α-MSH acted as a mitogen by increasing levels of cyclinD1 and retinoblastoma protein; as a result NSC proliferation was doubled. Finally, BRCA-1 is expressed while NSCs proliferate, but is drastically down regulated upon differentiation, indicating that BRCA-1 could be used as a possible NSC marker. In summary, in this thesis estrogen and nandrolone were identified as NSC regulators which decrease proliferation and positively influence neurogenesis. Also, we have identified the hormone α-MSH as a NSC mitogen, and BRCA-1 as a possible NSC marker.

La différenciation cellulaire implique des facteurs clés. Chez la drosophile, le facteur de transcription Glide/Gcm est impliqué dans la différenciation de deux types de cellules immunitaires : les macrophages circulants, qui ont une origine hématopoïétique, et les cellules gliales, macrophages résidents du système nerveux central, qui sont issues des précurseurs neuraux. J'ai d'abord entrepris la caractérisation du potentiel hématopoïétique de Gcm et l'identification de ses cibles dans les hémocytes. Ensuite, pour comprendre comment plusieurs types cellulaires peuvent être spécifiés par un même facteur de transcription, j'ai étudié comment s'effectue le choix entre le destin glial et le destin hémocytaire de la cellule. J'ai en particulier misen évidence le rôle clé des gènes agissant en aval de Gcm, ceux impliqués dans la consolidation et le maintien de l'identité cellulaire. Finalement, j'ai participé à la caractérisation du territoire d'expression de Gcm au niveau protéique et découvert un nouveau rôle de Gcm dans la différenciation de cellules neurosécrétrices, cellules indispensable pour initier le signal hormonal déclenchant le phénomène de mue chez les insectes. / Cell fate determination involves key transcription factors. ln Drosophila, the transcription factor Glide/Gcm is required for the differentiation of two immune cell types: circulating macrophages,which arise from hematopoietic precursors, and glial cells, resident macrophages of the central nervous system, which differentiate from neural precursors. ln first, 1 characterized Gcm hematopoietic potential and identified its target genes in hemocytes. Then, to get an insight intomolecular mechanisms underlying the acquisition of several identities with a single fate determinant, 1 investigated how the choice between the hemocyte and the glial fates is regulated.Being necessary to consolidate and to maintain a specific fate, 1 highlight the key role of genes acting downstream of a fate determinant. Finally, 1 contribute to characterize Gcm expression profile at the protein level and highlight a new role of Gcm in the differentiation of neurosecretory cells, cells absolutely required to initiate the hormonal signal triggering the molting process in insects.